Quantcast

Synovial Sarcoma - Online Support Group

SBRT and PD-1 or PD-L1 inhibitor


#1

A new trial, not yet recruiting will test if adding SBRT to anti-PD-1 or anti-PD-L1 antibody helps patients who eventually progressed after an initial response to the antibodies alone: